Gilead to launch low-cost generic versions of its hepatitis drugs Medical Dialogues Bureau26 Sept 2018 9:00 AM ISTGilead said the low-cost variants of the drugs will be available at a list price of $24,000 for the most common course of therapy from January.New...
USFDA completes inspection of Biocon drug substance unit at Bengaluru Medical Dialogues Bureau25 Sept 2018 1:46 PM ISTNo ObservationsBanglore: Biotechnology major Biocon has said the inspection of its drug substance manufacturing site at Bengaluru campus by the US...
Cipla received USFDA approval for Albendazole Medical Dialogues Bureau25 Sept 2018 11:19 AM ISTAlbendazole is an anti-worm medication drug. It prevents newly hatched insect larvae (worms) from growing or multiplying in our body. Mumbai: Cipla...
With new blood test, Roche dives deeper into personal cancer care Medical Dialogues Bureau25 Sept 2018 9:42 AM ISTCancer is a disease of the genome and genomic profiling of every patient's tumour at the start of their treatment journey will provide transformative...
Bayer Subside Monsanto India appoints Cherukuri Ravishankar as new MD Medical Dialogues Bureau25 Sept 2018 9:00 AM ISTNew Delhi: Seed firm Monsanto India, a subsidiary of Bayer group, has recently announced the appointment of Cherukuri Ravishankar as the Managing...
Japan provides medical equipment worth Rs 1 billion Medical Dialogues Bureau25 Sept 2018 9:00 AM ISTJICA had provided support for construction of physical infrastructure and medical equipment to TUTH in 1983 for the first time and in 1992 for the...
Gufic Biosciences board approves amalgamation with Gufic Lifesciences Medical Dialogues Bureau24 Sept 2018 4:43 PM ISTNew Delhi: Gufic Bioscience has recently announced that board has approved the scheme of amalgamation of Gufic Lifesciences with the company, in a...
AMD Drug: British Doctors Win; Novartis, Bayer, Roche Lose Medical Dialogues Bureau24 Sept 2018 2:08 PM ISTZURICH: Drug giants Novartis, Bayer and Roche have recently lost a bid to stop British doctors from recommending a cheaper drug option for people with...
Wrong Labelling: Intas Pharma US arm recalls over 46,000 bottles of diuretic drug Medical Dialogues Bureau24 Sept 2018 12:38 PM ISTAccord Healthcare recall is based on "Labelling: label mix-up: customer complaint that a sealed bottle labelled as Hydrochlorothiazide tablets USP...
Bayer says Monsanto India integration to complete in one year Medical Dialogues Bureau24 Sept 2018 9:00 AM ISTBayer completed the USD 63 billion mega-deal to acquire US-based Monsanto to create the world's biggest agrochemical and seed company. New Delhi: It...
DOP rejects Review Petition of Lupin against ceiling price fixation for its combinations Medical Dialogues Bureau23 Sept 2018 12:39 PM IST Department of Pharmaceutical rejected the review petition of Lupin " Lupin has not implemented the price notification"New Delhi: Through a recent...
Inventia Healthcare files Rs 450-cr IPO papers with SEBI Medical Dialogues Bureau23 Sept 2018 10:00 AM ISTNEW DELHI: Inventia Healthcare has filed draft papers with capital markets regulator SEBI to raise an estimated Rs 450 crore through an initial public...
